Vertex Pharmaceuticals 통합
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionColdstream Capital Management Inc
Latest Disclosed Ownership6,537 shares
Latest Disclosed Value $ 2,919,034
Coldstream Capital Management Inc reports 8.91% increase in ownership of VRTX / Vertex Pharmaceuticals Incorporated

On May 8, 2026 - Coldstream Capital Management Inc filed a 13F-HR form disclosing ownership of 6,537 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $2,919,032 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 6,002 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 8.91% during the quarter. The current value of the position is $2,887,654 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 6,537 535 8.91 2,919 7.28 0.0313
2026-02-09 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 6,002 -404 -6.31 2,721 8.49 0.0351
2025-11-19 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 6,406 532 9.06 2,509 -4.09 0.0338
2025-08-12 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 5,874 711 13.77 2,615 4.47 0.0428
2025-05-13 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 5,163 267 5.45 2,503 26.99 0.0533
2025-02-14 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 4,896 122 2.56 1,972 -11.77 0.0420
2024-11-18 2024-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 4,774 552 13.07 2,235 12.94 0.0483
2024-11-18 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 4,774 2,235
2024-08-07 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 4,222 253 6.37 1,979 19.23 0.0482
2024-05-14 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,969 38 0.97 1,659 3.75 0.0421
2024-02-09 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,931 231 6.24 1,599 24.34 0.0447
2023-11-02 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,700 86 2.38 1,287 1.18 0.0420
2023-08-03 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,614 40 1.12 1,272 12.88 0.0403
2023-05-15 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,574 209 6.21 1,126 15.96 0.0378
2023-01-10 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,365 265 8.55 972 11.10 0.0356
2022-08-08 2022-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 3,100 473 18.01 874 27.41 0.0340
2022-08-08 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,763 -864 497 0.0211
2022-05-11 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,627 58 2.26 686 21.63 0.0236
2022-02-11 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,569 1,212 89.31 564 52.85 0.0177
2021-11-12 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,357 260 23.70 369 66.97 0.0179
2021-08-16 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,097 28 2.62 221 -3.91 0.0089
2021-06-16 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,069 -280 -20.76 230 -27.90 0.0135
2021-02-16 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,349 215 18.96 319 3.57 0.0192
2020-11-16 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,134 5 0.44 308 -5.81 0.0256
2020-08-12 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,129 20 1.80 327 24.33 0.0294
2020-05-27 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,109 159 16.74 263 26.44 0.0287
2020-02-13 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 950 950 208 0.0171
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.